Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Helsinn patents

Patents where

Current Assignee

Name

Helsinn

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11299472 Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereof	Patent 11299472 was granted and assigned to Helsinn on April, 2022 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	11299472	April 12, 2022
‌ US Patent 7186755 Nimesulide gel systems for topical use	Patent 7186755 was granted and assigned to Helsinn on March, 2007 by the United States Patent and Trademark Office.		Helsinn	United States Patent and Trademark Office	7186755	March 6, 2007
‌ US Patent 10278964 Medical treatments based on anamorelin	Patent 10278964 was granted and assigned to Helsinn on May, 2019 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	10278964	May 7, 2019
‌ US Patent 9186357 Compositions and methods for treating centrally mediated nausea and vomiting	Patent 9186357 was granted and assigned to Helsinn on November, 2015 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9186357	November 17, 2015
‌ US Patent 8623826 Compositions and methods for treating centrally mediated nausea and vomiting	Patent 8623826 was granted and assigned to Helsinn on January, 2014 by the United States Patent and Trademark Office.		Helsinn	United States Patent and Trademark Office	8623826	January 7, 2014
‌ US Patent 9675600 Medical treatments based on anamorelin	Patent 9675600 was granted and assigned to Helsinn on June, 2017 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9675600	June 13, 2017
‌ US Patent 9908907 Substituted piperaziniums for the treatment of emesis	Patent 9908907 was granted and assigned to Helsinn on March, 2018 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9908907	March 6, 2018
‌ US Patent 9439854 Liquid pharmaceutical formulations of palonosetron	Patent 9439854 was granted and assigned to Helsinn on September, 2016 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9439854	September 13, 2016
‌ US Patent 10208073 Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator	Patent 10208073 was granted and assigned to Helsinn on February, 2019 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	10208073	February 19, 2019
‌ US Patent 8426450 Substituted 4-phenyl pyridines having anti-emetic effect	Patent 8426450 was granted and assigned to Helsinn on April, 2013 by the United States Patent and Trademark Office.		Helsinn	United States Patent and Trademark Office	8426450	April 23, 2013
‌ US Patent 9457020 Liquid pharmaceutical formulations of palonosetron	Patent 9457020 was granted and assigned to Helsinn on October, 2016 by the United States Patent and Trademark Office.		Helsinn	United States Patent and Trademark Office	9457020	October 4, 2016
‌ US Patent 8951969 Compositions and methods for treating centrally mediated nausea and vomiting	Patent 8951969 was granted and assigned to Helsinn on February, 2015 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	8951969	February 10, 2015
‌ US Patent 9926337 Substituted asymmetric ureas as modulators of ghrelin receptor activity	Patent 9926337 was granted and assigned to Helsinn on March, 2018 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9926337	March 27, 2018
‌ US Patent 9975921 Crystal forms of anamorelin	Patent 9975921 was granted and assigned to Helsinn on May, 2018 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9975921	May 22, 2018
‌ US Patent 10233154 Crystalline forms of an NK-1 antagonist	Patent 10233154 was granted and assigned to Helsinn on March, 2019 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	10233154	March 19, 2019
‌ US Patent 11312698 Fosnetupitant chloride hydrochloride having improved stability	Patent 11312698 was granted and assigned to Helsinn on April, 2022 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	11312698	April 26, 2022
‌ US Patent 10501479 Benzenesulfonyl-asymmetric ureas and medical uses thereof	Patent 10501479 was granted and assigned to Helsinn on December, 2019 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	10501479	December 10, 2019
‌ US Patent 9951016 Crystalline forms of an NK-1 antagonist	Patent 9951016 was granted and assigned to Helsinn on April, 2018 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9951016	April 24, 2018
‌ US Patent 10676440 Crystalline forms of an NK-1 antagonist		Helsinn	Helsinn	United States Patent and Trademark Office	10676440	June 9, 2020
‌ US Patent 9457021 Liquid pharmaceutical formulations of palonosetron	Patent 9457021 was granted and assigned to Helsinn on October, 2016 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9457021	October 4, 2016
‌ US Patent 9403772 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator	Patent 9403772 was granted and assigned to Helsinn on August, 2016 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9403772	August 2, 2016
‌ US Patent 9358228 Therapeutic combinations of netupitant and palonosetron	Patent 9358228 was granted and assigned to Helsinn on June, 2016 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9358228	June 7, 2016
‌ US Patent 10005803 Crystalline forms of fosnetupitant	Patent 10005803 was granted and assigned to Helsinn on June, 2018 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	10005803	June 26, 2018
‌ US Patent 9546157 Asymmetric piperidinyl-substituted ureas as medicines	Patent 9546157 was granted and assigned to Helsinn on January, 2017 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9546157	January 17, 2017
‌ US Patent 9271975 Compositions and methods for treating centrally mediated nausea and vomiting	Patent 9271975 was granted and assigned to Helsinn on March, 2016 by the United States Patent and Trademark Office.	Helsinn	Helsinn	United States Patent and Trademark Office	9271975	March 1, 2016

Results per page:

34 results

0 selected

34 results

0 selected